NO994736L - Fremgangsmåte for bestemmelse av aktiverte blodkoaguleringsfaktorer i plasma og plasmaderivater - Google Patents

Fremgangsmåte for bestemmelse av aktiverte blodkoaguleringsfaktorer i plasma og plasmaderivater

Info

Publication number
NO994736L
NO994736L NO994736A NO994736A NO994736L NO 994736 L NO994736 L NO 994736L NO 994736 A NO994736 A NO 994736A NO 994736 A NO994736 A NO 994736A NO 994736 L NO994736 L NO 994736L
Authority
NO
Norway
Prior art keywords
plasma
coagulation factors
derivatives
blood coagulation
activated blood
Prior art date
Application number
NO994736A
Other languages
English (en)
Norwegian (no)
Other versions
NO994736D0 (no
Inventor
Guenter Woeber
Beate Gesien
Original Assignee
Blutspendedienst Der Drk Lande
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blutspendedienst Der Drk Lande filed Critical Blutspendedienst Der Drk Lande
Publication of NO994736D0 publication Critical patent/NO994736D0/no
Publication of NO994736L publication Critical patent/NO994736L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO994736A 1997-04-09 1999-09-29 Fremgangsmåte for bestemmelse av aktiverte blodkoaguleringsfaktorer i plasma og plasmaderivater NO994736L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19714599 1997-04-09
PCT/EP1998/001264 WO1998045713A1 (de) 1997-04-09 1998-03-06 Verfahren zur bestimmung von aktivierten blutgerinnungsfaktoren in plasma und plasmaderivaten

Publications (2)

Publication Number Publication Date
NO994736D0 NO994736D0 (no) 1999-09-29
NO994736L true NO994736L (no) 1999-09-29

Family

ID=7825875

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994736A NO994736L (no) 1997-04-09 1999-09-29 Fremgangsmåte for bestemmelse av aktiverte blodkoaguleringsfaktorer i plasma og plasmaderivater

Country Status (5)

Country Link
US (1) US6124110A (de)
EP (1) EP0975975A1 (de)
CA (1) CA2286164A1 (de)
NO (1) NO994736L (de)
WO (1) WO1998045713A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US7247488B2 (en) * 2003-05-06 2007-07-24 Medtronic, Inc. Method and kit for testing a multi-channel blood assay cartridge
US20050221414A1 (en) * 2004-03-31 2005-10-06 Katalin Varadi Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
AT501650A1 (de) * 2005-02-22 2006-10-15 Technoclone Ges M B H Verfahren zur bestimmung der gerinnungsaktivierung sowie gerät zur durchführung des verfahrens
US8071545B2 (en) * 2005-03-15 2011-12-06 Lewis S. Coleman, Md, Inc. Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism
SE1050124A1 (sv) * 2010-02-08 2011-08-09 Linkoping Biocontrols Ab Stabil lösning
WO2011148207A1 (en) 2010-05-28 2011-12-01 Diagon Kft. Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents
CN107356768A (zh) * 2017-06-23 2017-11-17 宁波艾科生物科技有限公司 一种液体即用型凝血酶原时间检测试剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516579A1 (de) * 1984-11-19 1986-05-22 Boehringer Mannheim Gmbh, 6800 Mannheim Gerinnungstest auf teststreifen
US5472850A (en) * 1991-04-10 1995-12-05 Oklahoma Medical Research Foundation Quantitative clotting assay for activated factor VII
ATE267250T1 (de) * 1995-03-03 2004-06-15 Eisai Co Ltd Prothrombin aktivierendes enzym, das kalzium benötigt
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin

Also Published As

Publication number Publication date
NO994736D0 (no) 1999-09-29
WO1998045713A1 (de) 1998-10-15
US6124110A (en) 2000-09-26
CA2286164A1 (en) 1998-10-15
EP0975975A1 (de) 2000-02-02

Similar Documents

Publication Publication Date Title
Kluft Studies on the fibrinolytic system in human plasma: quantitative determination of plasminogen activators and proactivators
NO994736L (no) Fremgangsmåte for bestemmelse av aktiverte blodkoaguleringsfaktorer i plasma og plasmaderivater
Schlessinger et al. Turnover of protein in Escherichia coli starving for nitrogen
DK171086B1 (da) Fremgangsmåde til fotometrisk bestemmelse af protein C- og/eller protein S-aktivitet
NO932855L (no) Fremgangsmaate og materiale for bestemmelse av kaliumioneri fluider
Dejana et al. Prostacyclin production by human endothelial and bovine smooth muscle cells in culture: Effect of repeated stimulation with arachidonic acid, thrombin and ionophore A23187
DK165199B (da) Aktivatorpraeparat, fremgangsmaade til kvantitativ bestemmelse af protein c under anvendelse af praeparatet, antithrombotisk laegemiddel indeholdende praeparatet og fremgangsmaade til udvinding af aktiveret protein c under anvendelse af praeparatet
Bagge et al. Coagulation, fibrinolysis and bleeding after open-heart surgery
Rangachari Histamine release by gastric stimulants
JP2003517610A (ja) 血液学的アッセイ及び試薬
IE790238L (en) Biological activity of heparin in plasma
Russo et al. The effects of glutathione depletion on thermotolerance and heat stress protein synthesis
Verhoeven et al. Metabolic energy is required in human platelets at any stage during optical aggregation and secretion
Munro et al. Effects of external osmolality on polyamine metabolism in HeLa cells
DE3268329D1 (en) Process for the quantitative determination of the blood clotting factor xii in human plasma
Kluft Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator
DK0830608T3 (da) Thromboseriskotest
Storelli et al. Polar distribution of sodium-dependent and sodium-independent transport system for L-lactate in the plasma membrane of rat enterocytes
Portilla et al. Protein kinase C modulates phospholipase C and increases arachidonic acid release in bradykinin stimulated MDCK cells
Blezer et al. Activation of blood coagulation at heparin‐coated surfaces
Wagenvoord et al. Development of a simple chromogenic factor VIII assay for clinical use
Boyer et al. Thrombin generation and formation of thrombin-antithrombin III complexes in congenital antithrombin III deficiency
Adamo et al. Expression of differentiative traits in the absence of cell fusion during myogenesis in culture
Kjalke et al. Effect of recombinant factor VIIa (NovoSeven®) on thrombocytopenia-like conditions in vitro
Wallace et al. Activation of ADP-ribosyltransferase in polyamine-depleted mammalian cells